Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004828 |
---|---|
Receipt number | R000005747 |
Scientific Title | A phase I clinical study of immune cell therapy with MAGE-A4- or Survivin-specific Th1 cells for patients with refractory virulent tumors |
Date of disclosure of the study information | 2011/01/07 |
Last modified on | 2013/10/09 18:21:31 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/01/06 15:10:46 | ||
2 | Update | 2011/01/07 10:12:39 | UMIN ID1 |
|
3 | Update | 2011/09/15 12:37:20 | Recruitment status |
|
4 | Update | 2012/01/06 10:12:05 | Recruitment status |
|
5 | Update | 2012/05/02 11:56:24 | UMIN ID2 |
|
6 | Update | 2013/10/09 18:21:31 | Recruitment status |